Please provide your email address to receive an email when new articles are posted on . Among South-East Asian adults, bisphosphonate use in is not associated with differences in clinical outcomes or ...

Long-term treatment with a bisphosphonate degrades fracture-resistance–toughening mechanisms that contribute to healthy bone, setting the stage for the rare but catastrophic risk of patients ...

Simon et al reviewed the skeletal consequences of discontinuing HT and the specific treatment options for these women. [12] This analysis included 11 RCTs that reported data on BMD changes during and ...

Please provide your email address to receive an email when new articles are posted on . The human monoclonal antibody denosumab more effectively increases bone mass in patients with low bone mineral ...

Bisphosphonates are a class of drugs that reduce the rate of bone turnover. Osteochemonecrosis is a drug-induced condition in which part of the jawbone dies and cannot regenerate due to lack of blood ...

About a year was determined to be the minimal timing of bisphosphonate therapy for postmenopausal women with osteoporosis to reap a benefit, according to a meta-analysis. Looking at 10 randomized ...

Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States: Expert Roundtable Recommendations We conducted a retrospective ...

MONTREAL -- Lengthy drug holidays among patients with osteoporosis using bisphosphonates resulted in significantly increased risks of subsequent hip fractures, a researcher reported here at the ...

(HealthDay News) — Bisphosphonate use, especially over a long duration, is associated with increased risk of atypical femoral fracture, according to a study published in the September 4 issue of the ...

Since 2007, there have been several reports suggesting a potential association between the use of bisphosphonates and the occurrence of subtrochanteric or so-called atypical femoral fracture. 1–4 ...